Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 14, 2019 (8 years ago)

Dimercaptopropanesulfonate Sodium

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: Particulates observed in vials release for dispensing.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704

Recalling firm
McGuff Compounding Pharmacy Services, Inc.
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0821-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by McGuff Compounding Pharmacy Services, Inc.

All 2019 recalls

Other particulate / foreign matter recalls from 2019

All particulate / foreign matter recalls
Class I · High risk

Ketorolac Trom

Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.

Terminated Particulate / foreign matter RemedyRepack Inc. NDC 70518-1239-00 D-0867-2020